Application of Cobalt (II)-EDTA Complex as a Reductant for Molybdophosphoric Acid Used for the Spectrophotometric Assay of Aciclovir, Fluconazole, Ramipril and Secnidazole

M. El-Azazy, Magda Y El-Mammli, A. Shalaby, M. Ayad
{"title":"Application of Cobalt (II)-EDTA Complex as a Reductant for Molybdophosphoric Acid Used for the Spectrophotometric Assay of Aciclovir, Fluconazole, Ramipril and Secnidazole","authors":"M. El-Azazy, Magda Y El-Mammli, A. Shalaby, M. Ayad","doi":"10.7019/TPJ.200909.0043","DOIUrl":null,"url":null,"abstract":"A new spectrophotometric method has been described for the assay of aciclovir, fluconazole, ramipril and secnidazole based on formation of insoluble molecular complexes with molybdophosphoric acid (MPA) under acidic conditions. As a second step, a colour reaction has been combined to determine MI’A, released from the complex (and the studied drugs in turn), using a chromogenic reductant; cobalt (Ⅱ)-EDTA complex to produce molybdenum blue Mo(subscript 5+). The colour of the produced Mo(subscript 5+) is measured at 700-710 nm. Appropriate conditions were established for the precipitation and the colour reactions to obtain maximum sensitivity. Under the proposed conditions, this method is applicable over concentration range of 40-580μg ML^(-1). The results demonstrated that the proposed method is equally accurate, precise and reproducible as the official or reported methods thus it is recommended for quality control and routine analysis where time, cost effectiveness and high specificity of analytical techniques are of great importance.","PeriodicalId":22409,"journal":{"name":"The Chinese Pharmaceutical Journal","volume":"272 1","pages":"43-51"},"PeriodicalIF":0.0000,"publicationDate":"2009-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Chinese Pharmaceutical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7019/TPJ.200909.0043","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

A new spectrophotometric method has been described for the assay of aciclovir, fluconazole, ramipril and secnidazole based on formation of insoluble molecular complexes with molybdophosphoric acid (MPA) under acidic conditions. As a second step, a colour reaction has been combined to determine MI’A, released from the complex (and the studied drugs in turn), using a chromogenic reductant; cobalt (Ⅱ)-EDTA complex to produce molybdenum blue Mo(subscript 5+). The colour of the produced Mo(subscript 5+) is measured at 700-710 nm. Appropriate conditions were established for the precipitation and the colour reactions to obtain maximum sensitivity. Under the proposed conditions, this method is applicable over concentration range of 40-580μg ML^(-1). The results demonstrated that the proposed method is equally accurate, precise and reproducible as the official or reported methods thus it is recommended for quality control and routine analysis where time, cost effectiveness and high specificity of analytical techniques are of great importance.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
钴(II)-EDTA配合物作为钼磷酸还原剂在阿昔洛韦、氟康唑、雷米普利和塞克硝唑的分光光度测定中的应用
建立了一种在酸性条件下与钼磷酸(MPA)形成不溶性分子配合物的分光光度法测定阿昔洛韦、氟康唑、雷米普利和塞克硝唑的新方法。作为第二步,使用显色还原剂,结合显色反应来确定从复合物(以及所研究的药物)中释放的MI 'A;钴(Ⅱ)-EDTA络合物生成钼蓝Mo(下标5+)。生成的Mo(下标5+)的颜色在700-710 nm处测量。建立了沉淀和显色反应的适宜条件,以获得最大的灵敏度。在此条件下,该方法适用于40 ~ 580μg ML^(-1)的浓度范围。结果表明,该方法与官方或报道的方法同样准确,精确和可重复性,因此建议用于质量控制和常规分析,其中时间,成本效益和分析技术的高特异性非常重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Research Progress of Pharmacokinetic Interactions between Lopinavir/Ritonavir and Statins Results and Discussion on National Vaccine Proficiency Testing Schemes in 2020 Case Study of Icotinib on The Impact of Domestic Innovative Drugs Timely Covered by Medical Insurance Evaluation of α-Interferon Applied in COVID-19 Therapy Regimen Detection and Analysis of Safety Signals of Chloroquine Based Upon FDA Adverse Event Database
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1